The thin line: gas-phase polymeric coatings
Williams, D.
Medical Device Technology 6(10): 7-10
1995
ISSN/ISBN: 1048-6690 PMID: 10158123 Document Number: 450869
Medical devices often need some form of protection from their immediate environment. However, with small, complex, and sensitive components, the application of a protective coating is not a trivial matter. This article discusses the problem and describes a solution.
Document emailed within 1 workday
Related Documents
Mattioli-Belmonte, M.; Orciani, M.; Ferretti, C.; Orsini, G.; De Giglio, E.; Di Primio, R. 2010: Cell behaviour on bioactive polymeric coatings Italian Journal of Anatomy and Embryology 115(1-2): 127-133Thoma, K.; Heckenmüller, H. 1986: Thin layer chromatographic detection of emollients in gastric juice-resistant coatings. 2. the pharmaceutic technology and analysis of gastric juice-resistant dosage forms Die Pharmazie 41(5): 328-332
Young, M.S. 1998: Preparation of environmental samples for determination of sulfonylurea herbicides by solid-phase extraction using a polymeric sorbent Journal - Association of Official Analytical Chemists 81(1): 99-104
Picozzi, K.; Fèvre, E.M.; Odiit, M.; Carrington, M.; Eisler, M.C.; Maudlin, I.; Welburn, S.C. 2005: Sleeping sickness in Uganda: a thin line between two fatal diseases BMJ 331(7527): 1238-1241
Toh, H.C. 2000: High dose chemotherapy in breast cancer--a thin red line between hype and hope Singapore Medical Journal 41(2): 86-88
Gröningsson, K. 1970: Thin-ayer chromatography of ion pairs on impregnated layers. II. Reversed-phase systems Acta Pharmaceutica Suecica 7(6): 635-650
Rong, F.; Li, P.; Feng, X.; Yuan, C.; Fu, D. 2006: Preparation and evaluation of molecularly imprinted stationary phase used for thin-layer chromatography Se Pu 24(3): 305-308
Zhou, X.; Lin, L.M.; Zhang, J.; Chen, J.P.; Wang, L.X. 2000: A preliminary study of the quantitative structure-retention relationship of ginsenosides in normal phase thin-layer chromatography Se Pu 18(3): 206-211
Liang, Q.-d.; Li, W.-h.; Wang, H.-x.; Wang, S.-q. 2003: Saccharide analysis of si-wu-tang by automated multiple development and off-line coupling thin layer chromatography electrospray ionization mass spectrometry techniques Zhongguo Zhong Yao Za Zhi 28(7): 632-635
Stadler, A. 1992: Thermoformen : Mehrschichtoprodukte im In-line-und Halb-in-line-Verfahren - Thermoforming: multi-layer products produced by in-line and semi-in-line processes Plastverarbeiter 43(6): 110-113
Pezzi, R. 1971: Ultrastructure of cells of the 37RC line infected with poliovirus. II. Late phase Rivista di Biologia 64(2): 203-214
Scotto, V.; Sbiroli, C. 1991: Weekly cis-platinum as third line chemotherapy in advanced ovarian carcinoma. Phase Ii study European Journal of Gynaecological Oncology 12(1): 51-53
Chitapanarux, I.; Tonusin, A.; Sukthomya, V.; Charuchinda, C.; Pukanhapan, N.; Lorvidhaya, V. 2003: Phase II clinical study of irinotecan and cisplatin as first-line chemotherapy in metastatic or recurrent cervical cancer Gynecologic Oncology 89(3): 402-407
Ciuleanu, T.E.; Curcă, R.; Iancu, D.; Todor, N.; Cebotaru, C.; Radulescu, I.; Banu, E.; Ghilezan, N. 2002: First-line chemotherapy with topotecan and etoposide in advanced small cell lung cancer. a phase Ii study Journal of Buon: Official Journal of the Balkan Union of Oncology 7(1): 43-46
Kunisaki, C.; Imada, T.; Yamada, R.; Hatori, S.; Ono, H.; Otsuka, Y.; Matsuda, G.; Nomura, M.; Akiyama, H.; Kubo, A.; Shimada, H. 2005: Phase II study of docetaxel plus cisplatin as a second-line combined therapy in patients with advanced gastric carcinoma Anticancer Research 25(4): 2973-2977
Ryo, H.; Toyama, K.; Isobe, K.; Sugino, K.; Sano, G.; Yamada, H.; Hiroi, M.; Hojyo, T.; Kimura, K. 2003: A phase I study of gemcitabine and irinotecan as second line treatment for advanced non-small cell lung cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 30(2): 237-242
Vici, P.; Giotta, F.; DI Lauro, L.; Brandi, M.; Gebbia, V.; Foggi, P.; Lorusso, V.; Vitucci, C.; Sergi, D.; Fattoruso, S.I.; Giannarelli, D.; Viola, G.; Corsetti, S.; Colucci, G.; Lopez, M. 2009: Multicenter phase Ii trial of first-line docetaxel/gemcitabine in advanced breast cancer pretreated with adjuvant anthracyclines Anticancer Research 29(5): 1841-1845
Han, E.K.; Sgambato, A.; Jiang, W.; Zhang, Y.J.; Santella, R.M.; Doki, Y.; Cacace, A.M.; Schieren, I.; Weinstein, I.B. 1995: Stable overexpression of cyclin D1 in a human mammary epithelial cell line prolongs the S-phase and inhibits growth Oncogene 10(5): 953-961
Lück, H.J.; Thomssen, C.; du Bois, A.; Lisboa, B.W.; Untch, M.; Kühnle, H.; Jänicke, F.; Meerpohl, H.G.; Lindner, C.; Konecny, G.; Hecker, D.; Diergarten, K. 1997: Preliminary results of a phase Ii study of epirubicin and paclitaxel as first-line treatment in patients with metastatic breast cancer Seminars in Oncology 24(1 Suppl 3: S13-S16
Giannakakis, T.; Kakolyris, S.; Theodoropoulos, E.; Kouroussis, C.; Michailakis, E.; Papadouris, S.; Tsitoura, M.; Kalbakis, K.; Souglakos, J.; Agelaki, S.; Vardakis, N.; Georgoulias, V. 2002: A multicenter phase Ii study of docetaxel and carboplatin combination as front-line treatment in advanced non-small cell lung cancer Anticancer Research 22(6b): 3743-3748